Science
Myeloma Paper of the Day, July 24th, Suggested by Robert Orlowski

Myeloma Paper of the Day, July 24th, Suggested by Robert Orlowski

Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:

“Myeloma paper of the Day:

Pilot trial of lenalidomide, oral azacitidine + XRT for newly diagnosed and relapsed plasmacytoma shows median PFS or TTP of 16.3 mos (95% CI 14.3-not reached) in cohort 1 and 10.4 months (95% CI 6.4-not reached) in cohort 2.”

Title: A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma

Authors: Urvi A. Shah, Andriy Derkach, Meghana Pagadala, Kelly Barnett, Sean Devlin, Sham Mailankody, Neha Korde, Malin Hultcrantz, Carlyn Tan, Francesco Maura, Kylee Maclachlan, Gunjan L. Shah, Michael Scordo, Parastoo B. Dahi, Heather J. Landau, Hani Hassoun, Oscar B. Lahoud, Ola Landgren, Jonathan Landa, Bernard O’Malley, Sergio Giralt, Brandon S. Imber, Christopher A. Barker, Saad Z. Usmani, Taha Merghoub, Joachim Yahalom, Alexander M. Lesokhin

You can read the Full Article on Haematologica.

Myeloma Paper of the Day, July 24th, Suggested by Robert Orlowski

You can find other articles featuring Robert Orlowski on OncoDaily.

 

Alexander M. Lesokhin Andriy Derkach Bernard O’Malley Brandon S. Imber cancer Carlyn Tan Christopher A. Barker Francesco Maura Gunjan L. Shah Haematologica Hani Hassoun Heather J. Landau Joachim Yahalom Jonathan Landa Kelly Barnett Kylee Maclachlan Malin Hultcrantz Meghana Pagadala Michael Scordo Myeloma Paper of the Day Neha Korde Ola Landgren OncoDaily Oncology Oscar B. Lahoud Parastoo B Dahi Robert Orlowski Saad Z. Usmani Sean Devlin Sergio Giralt Sham Mailankody Taha Merghoub Urvi A. Shah